ÂÜÀòÂÒÂ×

Mohammed Homman-Loudiye has extensive work experience in the biotechnology and pharmaceutical industries. Mohammed is the Chairman of the Board and Founder of Vironova AB, a Swedish biotechnology company specializing in viral safety testing of pharmaceutical products. Mohammed also serves as the Chairman of the Board and Founder of Vironova Biosafety AB, which ensures virus safety in the manufacture of biopharmaceuticals. Additionally, Homman-Loudiye founded Vironova Medical AB, where they serve as the Chairman of the Board of Directors. In this role, they are involved in the development of novel antiviral compounds. Prior to these roles, Homman-Loudiye was the President of Intelligent Virus Imaging Inc.

Mohammed Homman-Loudiye began their education at Uppsala University in 1993 and completed their studies in 1998. During this time, they earned a Master of Science (M.Sc) degree in Chemistry and a Bachelor of Science (B.Sc) degree in Biology. In 1997, they briefly studied Biochemistry at the University of Twente for one year. Furthermore, in 1995 and 1996, they completed their Military Service at Lv3 Norrtälje. Mohammed then returned to academic studies at Karolinska Institutet in 1998, where they obtained a Bachelor of Science (B.Sc) degree in Biology focused on the replication cycle of Cytomeglovirus. Currently, their education journey continues at Karolinska Institutet as they pursue a Doctor of Philosophy (Ph.D.) in Experimental Medicine, which they have not yet completed as of the provided information.